Company-wide revenue
Reported revenue in 2021 ¥10.93B Reported revenue in 2025 ¥7.64B
- growth amount
- −¥3.29B
- growth annualized
- -8.6%
- growth total
- -30.1%
Japanese company profile · 2158
In its FY2025 public filing, FRONTEO,Inc. reports Life science AI, Risk management, DX. The page shows business-level revenue and profit where the source disclosures support comparison.
Original Japanese company name: 株式会社FRONTEO
English company name recorded in Japan's EDINET filer data. English company name source
What does this company do?
FRONTEO,Inc.'s largest reported business by revenue in FY2025 was Risk management.
The business with the highest reported segment profit in FY2025 was Risk management.
FY2025 · fiscal year ended March 2026 View original filing ↗ The source document may be in Japanese.
Business structure
| Business | Sales | Revenue share | Operating profit |
|---|---|---|---|
| Risk management | ¥4.02B ↗ | 52.6% | ¥605.57M ↗ |
| Business label unavailable in English | ¥2.6B ↗ | 34.1% | ¥161.91M ↗ |
| Life science AI | ¥1.03B ↗ | 13.5% | −¥16.18M ↗ |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended March 2026. Revenue and profit are shown only where the filing and data support a comparison.
What is growing?
Reported revenue in 2021 ¥10.93B Reported revenue in 2025 ¥7.64B
This describes a reported period; it is not a forecast.
What has changed?
Not disclosed or not safely comparable in the available filings.
Source
FY2025 · fiscal year ended March 2026
The source document may be in Japanese.
Filing ID: S100YGJA
View original filing ↗Ask about this company
The source document may be in Japanese.